Birdwatch Note
2024-09-19 11:07:48 UTC - NOT_MISLEADING
A case study which may help to understand the OP better: "Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA VACCINATION" Kawthar Jarrah,a,1 Layal Al Mahmasani,a,1 Ali Atoui,a Rayan Bou-Fakhredin,b and Ali T. Tahera https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716432/
Written by DD2AED8BEA920887A05750C5442690091EFBD1D5A61560EC922F50D62E563DF6
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1836436411613909078
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1836723862416879842
- noteId - 1836723862416879842
- participantId -
- noteAuthorParticipantId - DD2AED8BEA920887A05750C5442690091EFBD1D5A61560EC922F50D62E563DF6 Participant Details
- createdAtMillis - 1726744068138
- tweetId - 1836436411613909078
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- A case study which may help to understand the OP better: "Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA VACCINATION" Kawthar Jarrah,a,1 Layal Al Mahmasani,a,1 Ali Atoui,a Rayan Bou-Fakhredin,b and Ali T. Tahera https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716432/
Note Ratings
| rated at | rated by | |
| 2024-09-28 13:54:04 -0500 | Rating Details | |
| 2024-09-23 17:42:33 -0500 | Rating Details | |
| 2024-09-23 14:46:15 -0500 | Rating Details | |
| 2024-09-21 12:27:44 -0500 | Rating Details | |
| 2024-09-21 11:17:26 -0500 | Rating Details | |
| 2024-09-21 08:21:11 -0500 | Rating Details | |
| 2024-09-21 05:16:22 -0500 | Rating Details | |
| 2024-09-21 04:05:11 -0500 | Rating Details | |
| 2024-09-21 01:57:00 -0500 | Rating Details | |
| 2024-09-20 14:51:07 -0500 | Rating Details | |
| 2024-09-20 12:27:21 -0500 | Rating Details | |
| 2024-09-20 07:52:30 -0500 | Rating Details | |
| 2024-09-20 06:11:14 -0500 | Rating Details | |
| 2024-09-20 06:06:38 -0500 | Rating Details | |
| 2024-09-20 02:01:07 -0500 | Rating Details | |
| 2024-09-20 01:47:29 -0500 | Rating Details | |
| 2024-09-20 00:19:52 -0500 | Rating Details | |
| 2024-09-19 21:57:46 -0500 | Rating Details | |
| 2024-09-19 21:05:21 -0500 | Rating Details | |
| 2024-09-19 19:43:09 -0500 | Rating Details | |
| 2024-09-19 18:49:38 -0500 | Rating Details | |
| 2024-09-19 18:21:21 -0500 | Rating Details | |
| 2024-09-19 18:09:52 -0500 | Rating Details | |
| 2024-09-19 17:51:02 -0500 | Rating Details | |
| 2024-09-19 16:52:53 -0500 | Rating Details | |
| 2024-09-19 15:47:21 -0500 | Rating Details | |
| 2024-09-19 15:28:05 -0500 | Rating Details | |
| 2024-09-19 15:12:06 -0500 | Rating Details | |
| 2024-09-19 15:10:51 -0500 | Rating Details | |
| 2024-09-19 14:49:54 -0500 | Rating Details | |
| 2024-09-19 13:32:00 -0500 | Rating Details | |
| 2024-09-19 12:15:24 -0500 | Rating Details | |
| 2024-09-19 10:45:10 -0500 | Rating Details | |
| 2024-09-19 08:59:50 -0500 | Rating Details | |
| 2024-09-19 08:57:18 -0500 | Rating Details | |
| 2024-09-19 07:20:09 -0500 | Rating Details | |
| 2024-09-19 07:16:59 -0500 | Rating Details | |
| 2024-09-19 07:16:37 -0500 | Rating Details | |
| 2024-10-21 16:56:37 -0500 | Rating Details | |
| 2024-10-12 14:39:40 -0500 | Rating Details |